Lipoprotein (a) level in the population in Taiwan: Relationship to sociodemographic and atherosclerotic risk factors

Atherosclerosis

Volumn 143, Issue 2, 1999, Pages 267-273

  Chien, Kuo Liong ^a   Lee, Yuan Teh ^a   Sung, Fung Chang ^b   Su, Ta Chen ^a   Hsu, Hsiu Ching ^a   Lin, Ruey Shiung ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Atherosclerosis; Lipoprotein(a); Population based; Taiwanese

Indexed keywords

LIPOPROTEIN A;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CORONARY RISK; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS; TAIWAN;

ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; LIPOPROTEIN(A); LIPOPROTEINS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; RISK FACTORS; SEX CHARACTERISTICS; SOCIOECONOMIC FACTORS; TAIWAN;

EID: 0032928201     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00298-6     Document Type: Article

References (38)

1. Utermann G. The mysteries of lipoprotein (a). Science. 246:1989;904-910.
2. Zenker G., Koltringer P., Bone G., Niederkorn K., Pfeiffier K., Jurgens G. Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke. 17:1986;942-945.
3. Sandholzer C., Saha N., Kark J.D., Rees A., Jaross W., Dieplinger H., Hoppichler F., Boerwinkle E., Ultermann G. Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb. 12:1992;1214-1226.
4. McLean J.W., Tomlinson J.E., Kuang W.J., Eaton D.L., Chen E.Y., Fless G.M., Scanu A.M., Lawn R.M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 330:1987;132-137.
5. Mori J., Sasaki J., Kawaguchi H., Handa K., Takada Y., Matsunaga A., Kono S., Arakawa K. Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J. 129(2):1995;234-238.
6. Scanu lipoprotein (a) and atherosclerosis. Ann. J. Med. 1991;115:209-218.
7. Jenner J.L., Ordovas J.M., Lamon-Fava S., Schaefer M.M., Wwilson P.W.F., Castelli W.P., Schaefer E.J. Effects of age, sex and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation. 87:1993;1135-1141.
8. Slunga L., Asplund K., Johnson O., Dahlen G.H. Lipoprotein(a) in a randomly selected 25-64 year old population: The Northern Sweden MONICA Study. J Clin Epidemiol. 46:1993;617-624.
9. Brown S.A., Hutchinson R., Morrisett J., Boerwinkle E., Davis C.E., Gotto A.M. Jr Patsch W. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. Arterioscler Thromb. 13:1993;1139-1158.
10. Gurakar A., Hoeg J.M., Kostner G., Papadopoulos N.M., Brewer H.B. Jr Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment. Atherosclerosis. 57:1985;293-301.
11. Sandholzer C., Saha N., Kark J.D., Ree A., Jaross W., Dieplinger H., Hoppichler F., Boerwinkle E., Utermann G. Apo(a) isofroms predict risk for coronary heart disease. A study in six populations. Artherioscler Thromb. 12:1992;1214-1226.
12. Woo J., Lam C.W. Association of serum lipoprotein(a) concentration with other cardiovascular risk factors in a Chinese population. J Clin Lab Anal. 5(5):1991;335-339.
13. Cobbaert C., Kesteloot H. Serum lipoprotein(a) levels in racially different populations. Am J Epidemiol. 136(4):1992;441-449.
14. Taiwan: Reports of Department of Health. Executive Yuan, Republic of China. Taipei, Taiwan. 1995:134-147.
15. Chung M.Y., Jeng J.S., Yip P.K. Study on blood lipids, lipoproteins, and apolipoproteins in different types of ischemic stroke. Acta Neurol Sin. 3:1994;194-199.
16. Wieland H., Seidel D. A simple specific method for precipitation of low density lipoproteins. J Lipid Res. 24:1983;904-909.
17. Walford S. Insulin measurement. Pract Diabetes. 6:1989;56-58.
18. Shen M.C. One hundred and two cases of hemophilia A in Taiwan I. Clinical, laboratory and family studies. J Formosan Med Assoc. 81:1982;190-206.
19. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 153:1993;154-183.
20. Matthws D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
21. p. Technometrics. 15:1973;661-675.
22. SAS Institute. SAS/STAT software: changes and enhancements through Release 6.11. Cary, NC: SAS Institute, 1996:1104 pp.
23. Nago N., Kayaba K., Hiraoka J., Matuso H., Goto T., Kario K., Tsutsumi A., Nakamura Y., Igarashi M. Lipoprotein(a) levels in the Japanese Population: Influences of age and sex, and relation to atherosclerotic risk factors. Am J Epidemiol. 141:1995;815-821.
24. Howard B.V., Le N.A., Belcher J.D., Flack J.M., Kacobs D.R., Lewis C.E., Marcovina S.M., Perkins L.L. Concentrations of Lp(a) in Black and white young adults: relations to risk factors for cardiovascular disease. Ann Epidemiol. 4:1994;341-350.
25. Kario K., Matuo T., Imiya M., Kayaba K., Kuroda T., Nago N., Matsuo H., Shimada K. Close relation between lipoprotein (a) levels and atherosclerotic disease in Japanese subjects>75 years of age. Am J Cardiol. 73:1994;1187-1190.
26. Schreiner P.J., Heiss G., Tyroler H.A., Morrisett J.D., Kavis C.E., Smith R. Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol. 16:1996;471-478.
27. Anderson A.J., Sobocinski K.A., Freedman D.S., Barboriak J.J., Rimm A.A., Gruchow H.W. Body fat distribution, plasma lipids, and lipoproteins. Arteriosclerosis. 8:1988;88-94.
28. De Pergola G., Giorgino F., Cospite M.R., Giagulli V.A., Cignarelli M., Ferri G., Giorgino R. Relation between sex hormones and serum lipoprotein and lipoprotein(a) concentrations in pre-menopausal obese women. Arterioscler Thromb. 13:1993;675-679.
29. Bartens W., Rader D.J., Talley G., Brewer B. Jr Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia. Atherosclerosis. 108:1994;149-157.
30. Assmann G., Schulte H., Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol. 77:1996;1179-1184.
31. Leaf D.A. Women and coronary artery disease: gender confers no immunity. Postgrad Med. 87:1990;55-60.
32. Krolewski A.S., Warram J.H., Valsania P., Martin B.C., Laffel L.M.B., Christlieb R. Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med. 90(Suppl 2A):1991;56S-61S.
33. Genest J., Jenner J.L., McNamara J.R., Ordovas J.M., Silbermann S.R., Wilson P.W., Schaefer E.J. Prevalence of lipoprotein(a) excess in coronary heart disease. Am J Cardiol. 67:1991;1039-1045.
34. Rhoads G.G., Dahlen G., Berg K., Morton N.E., Dannenberg A.L. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc. 256:1986;2540-2544.
35. Ridker P.M., Hannekens C.H., Stampfer M.J. A prospective study of lipoprotein (a) and the risk of myocardial infarction. J Am Med Assoc. 270:1993;2195-2199.
36. Lobo R.A., Notelovitz M., Bernstein L., Khan F.Y., Ross R.K., Paul W.L. Lp(a) lipoprotein: relationship to cardiovascular diseases risk factors, exercise, and estrogen. Am J Obstet Gynecol. 166:1992;1182-1190.
37. Folsom A.R., Wu K.K., Davis C.E., Conlan M.G., Sorlie P.D., Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis. 91:1991;191-205.
38. Heinrich J., Sandkamp M., Kokott R., Schulte H., Assmann G. Relationship of lipoprotein(a) to variables to coagulation and fibrinolysis in a healthy population. Clin Chem. 37:1991;1950-1954.